New cancer drug FP008 enters first human trial
NCT ID NCT06990698
First seen Nov 01, 2025 · Last updated Jun 10, 2026 · Updated 28 times
Summary
This early-phase study tests a new drug called FP008 in 108 adults with advanced solid tumors. The main goal is to check the drug's safety and find the right dose. Researchers will also look at how the drug moves through the body and whether it helps shrink tumors. This is a first step to see if FP008 might be a future treatment option.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hubei Cancer Hospital
RECRUITINGWuhan, Hubei, 430014, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Shanxi Cancer Hospital
RECRUITINGTaiyuan, Shanxi, 030013, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Zhejiang Cancer Hospital
RECRUITINGHangzhou, Zhejiang, 310022, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.